EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Children's heartburn drug study halted early
Disease control TerminatedThis study looked at whether a full or half dose of pantoprazole could keep the esophagus healed in children aged 1 to 17 who had erosive esophagitis. The goal was to see which dose worked better and was safer. The study was stopped early, so results are limited.
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Children's heartburn drug trial halted early – but data may still help
Disease control TerminatedThis study tested a daily medicine called dexlansoprazole to heal and prevent return of erosive esophagitis (damage to the esophagus from stomach acid) in children aged 2 to 11 years. The trial was stopped early, but researchers aimed to see if the drug could heal the esophagus w…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC